LY2228820 : A phase 1 dose-escalation study of checkpoint kinase 1 (CHK1) inhibitor prexasertib in combination with p38 mitogen-activated protein kinase (p38 MAPK) inhibitor ralimetinib in patients with advanced or metastatic cancer
AZD1390 : Multicellular Complex Tumor Spheroid Response to DNA Repair Inhibitors in Combination with DNA-damaging Drugs
Epinephrine bitartrate : Expired Epinephrine Maintains Chemical Concentration and Sterility
Bisindolylmaleimide IX : Bisindolylmaleimide IX facilitates extrinsic and initiates intrinsic apoptosis in TNF-a-resistant human colon adenocarcinoma COLO 205 cells
TAPI-1 : GRO-α/CXCR2 System and ADAM17 Correlated Expression in Sjögren’s Syndrome